Research progress on androgen receptor in triple-negative breast carcinoma / 中国癌症杂志
China Oncology
; (12): 466-470, 2016.
Article
en Zh
| WPRIM
| ID: wpr-490137
Biblioteca responsable:
WPRO
ABSTRACT
Triple-negative breast cancers (TNBC) comprise a heterogeneous group of tumors characterized by poor survival and lack of targeted therapeutics. In recent years, androgen receptor (AR) has been demonstrated to play an important role in the genesis and development of TNBC. There has been increased interest in the role of AR in TNBC and AR-targeting has been introduced as a novel therapeutic option for TNBC. This review offers an overview of the relationship between AR expression and TNBC, and provides insights into the novel drugs in the development for targeting this signaling pathway.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
China Oncology
Año:
2016
Tipo del documento:
Article